Colgate-Palmolive (India) Ltd (COLPAL)
🎯 Key Takeaways
- Colgate-Palmolive (India) Ltd maintains a dominant market position in oral care and FMCG with strong profitability metrics, but faces headwinds from flat revenue growth and margin pressure. The company operates with a near-zero debt profile and exceptional returns on equity and capital, reflecting its asset-light, high-margin business model.
- Revenue grew 0.5% QoQ to ₹1,603 in Q1FY27.
- ⚠️ 1) Stagnant revenue growth over multiple quarters raises concerns about demand saturation or competitive pressure in core categories. 2) Operating mar
- Market Cap
- ₹48,957
- P/E Ratio
- 36.3
- P/B Ratio
- 30.91
- ROE
- 85.1%
- ROCE
- 114.8%
- Debt/Equity
- 0.00
- Div Yield
- 1.11%
- Promoter
- 51.0%
📖 The Story
Colgate-Palmolive (India) Ltd maintains a dominant market position in oral care and FMCG with strong profitability metrics, but faces headwinds from flat revenue growth and margin pressure. The company operates with a near-zero debt profile and exceptional returns on equity and capital, reflecting its asset-light, high-margin business model. However, its 1-year return of -21.45% indicates market concerns over near-term growth prospects despite consistent financial resilience.
📰 What's Happening
In July 2026, the company successfully concluded its 85th Annual General Meeting with unanimous shareholder approval of all resolutions, including director reappointments and financial statements, underscoring governance stability. The resignation of Internal Auditor G. Ramprasad on August 31, 2026, was noted as a routine transition without operational or strategic implications. These events reflect continuity in leadership and shareholder confidence, with no material changes to business strategy or capital structure announced recently.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,520 | 1,486 | 1,595 | 1,603 |
| Operating Profit | 428 | 406 | 475 | 444 |
| OPM % | 28.2% | 27.3% | 29.8% | 27.7% |
| Net Profit | 328 | 324 | 353 | 343 |
| EPS | ₹12.04 | ₹11.91 | ₹12.99 | ₹12.61 |
Revenue has remained largely flat over the past four quarters, growing from ₹1,486 crore in September 2025 to ₹1,603 crore in June 2026, with only marginal sequential expansion. While operating margins have held steady around 27-29%, they have slightly moderated from their peak of 29.8% in March 2026, suggesting possible pricing or input cost pressures. Net profit and EPS have shown modest volatility but remain stable, indicating effective cost management despite stagnant top-line growth.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance in the latest filings, but historical patterns and past communications suggest an emphasis on volume growth through market penetration and brand-led initiatives. The consistent reappointment of directors and approval of financials at the AGM imply confidence in near-term stability. However, absence of strategic updates or growth targets in recent disclosures suggests a cautious or status-quo approach to outlook communication.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 |
| Reserves | 1,637 | 1,626 | 1,557 | 1,555 |
| Borrowings | 61 | 70 | 0 | 60 |
| Total Liabilities | 3,019 | 3,248 | 3,408 | 3,178 |
| Fixed Assets | 776 | 822 | 718 | 742 |
| Investments | 0 | 0 | 0 | 0 |
| Total Assets | 3,019 | 3,248 | 3,408 | 3,178 |
The balance sheet remains exceptionally strong, with equity of ₹27 crore and reserves exceeding ₹1,550 crore, while borrowings have remained minimal (₹60 crore as of March 2026). Total assets have grown steadily, indicating operational expansion without leverage. This robust capital base supports financial resilience and provides flexibility for dividends, buybacks, or strategic investments without external financing needs.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +1,806 |
| Investing | +374 |
| Financing | -1,422 |
| Net Cash Flow | +758 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 51.0% | 51.0% | 51.0% | 51.0% |
| FII | 17.2% | 15.2% | 13.6% | 13.6% |
| DII | 12.2% | 13.8% | 15.5% | 15.8% |
| Public | 17.3% | 17.5% | 17.3% | 17.0% |
| # Shareholders | 3,32,409 | 3,37,608 | 3,33,741 | 3,26,817 |
Institutional investor interest has recently declined, with FII holding dropping from 17.16% in Q2FY26 to 13.59% in Q1FY27, and DII also trending downward from 15.53% to 13.78%. In contrast, promoter holding remains stable at 51%, and the number of public shareholders has slightly decreased. This suggests a potential rotation out of FII and DII positions, possibly due to valuation concerns or sector rotation, despite the company's strong fundamentals.
⚖️ Peer Comparison — FMCG
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| HINDUNILVR | 4.39 L Cr | 29.3 | 29.8% | — | 0.00 |
| ITC | 3.32 L Cr | 16.7 | 36.0% | — | 0.03 |
| NESTLEIND | 2.58 L Cr | 67.6 | 99.2% | — | 0.00 |
| VBL | 1.45 L Cr | 43.0 | 21.5% | — | 0.10 |
| LENSKART | 1.17 L Cr | 176.0 | 11.9% | — | 0.03 |
| BRITANNIA | 1.16 L Cr | 44.7 | 54.1% | — | 0.27 |
| MARICO | 1.03 L Cr | 54.4 | 54.2% | — | 0.08 |
| TATACONSUM | 95,699 | 58.5 | 10.2% | — | 0.10 |
| GODREJCP | 87,631 | 45.8 | 17.8% | — | 0.33 |
| DABUR | 67,419 | 34.2 | 21.3% | — | 0.09 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Stagnant revenue growth over multiple quarters raises concerns about demand saturation or competitive pressure in core categories. 2) Operating margin compression from March 2026 highs indicates possible margin erosion from input costs or promotional activity. 3) Declining FII/DII ownership may reduce liquidity support and institutional confidence. 4) Flat EPS growth despite high ROE suggests limited reinvestment opportunities or lack of catalysts for earnings expansion.
📋 Recent Filings
- 🔴 Announcement2026-09-30Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 🟡 Board Meeting2026-09-28Colgate-Palmolive (India) announced the resignation of Executive Vice President Legal Priyan Pillay effective October 23, 2026, to pursue an opportuni…
- 🟡 Board Meeting2026-09-28Colgate-Palmolive (India) announced the resignation of Executive Vice President Legal Priyan Pillay effective October 23, 2026, to pursue an overseas …
- Announcement2026-09-25Colgate-Palmolive (India) Ltd announced that its trading window will close on September 28, 2026, to prevent insider trading ahead of unaudited quarte…
- 🔴 Announcement2026-09-17Colgate-Palmolive (India) Ltd announced its schedule for an upcoming analyst and institutional investor meeting on September 23, 2026, at 09:00 a.m. I…
- 🔴 Announcement2026-09-10Colgate-Palmolive (India) announced a partnership with Kaun Banega Crorepati Season 18 to embed oral health messaging into the show's nightly sign-off…
- 🔴 Announcement2026-09-07Colgate-Palmolive (India) Ltd announced its participation in the UBS India Summit 2026 on September 11, 2026, at 10:00 a.m. IST, confirming attendance…
- 🔴 Announcement2026-08-31Colgate-Palmolive (India) announced the resignation of Internal Auditor G. Ramprasad effective August 31, 2026, to pursue external opportunities, mark…
- Announcement2026-08-21Colgate-Palmolive (India) held its Investor Day 2026 on August 17, 2026, outlining its oral care strategy, premiumization progress, and rural health i…
- Announcement2026-08-18Colgate PerioGard became India's first gum care regimen to earn the Indian Society of Periodontology's Seal of Acceptance, highlighting its clinical v…
🧠 Analyst's Read
Colgate-Palmolive (India) remains a high-quality, cash-generative business with exceptional returns and a pristine balance sheet, but its near-term trajectory appears to be transitioning from high-growth to stable maturity. Investors should monitor volume trends, margin trajectory, and any shift in capital allocation strategy — particularly around innovation or international expansion — as potential catalysts for re-rating beyond its current plateau.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when COLPAL files new disclosures
Track COLPAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track COLPAL — FreeFree account · 2 AI queries/day